EGFR and lung adenocarcinoma: Stevens-Johnson syndrome induced by toripalimab in a previously EGFR-TKI-treated advanced lung adenocarcinoma patient harboring <i>EGFR</i> mutations 19 del/T790M/C797S in <i>trans</i> and <i>cis</i>: a case report.